Fulcrum Therapeutics (FULC) Revenue (2020 - 2024)
Fulcrum Therapeutics' (FULC) quarterly Revenue came in at $80.0 million in Q2 2024, up 8990.91% year-on-year from $880000.0 in Q3 2023, and up 9084.85% on a QoQ basis from $871000.0 in Q4 2023.
Fulcrum Therapeutics (FULC) Revenue (2020 - 2024) Analysis & Trends
Fulcrum Therapeutics (FULC) has 5 years of Revenue data on file, last reported at $80.0 million in Q2 2024.
- On a quarterly basis, Revenue rose 8990.91% year-over-year to $80.0 million in Q2 2024; TTM through Jun 2025 was $80.0 million, a 2.0% decrease from a year earlier, with the FY2024 full-year figure at $80.0 million, up 2752.05% from the prior year.
- Revenue for Q2 2024 stood at $80.0 million, up from $871000.0 in the prior quarter.
- Over the last five years, Revenue for FULC reached as high as $80.0 million in Q2 2024 and fell as low as $295000.0 in Q1 2023.
- Historically, Revenue has averaged $6.9 million across 5 years, with a median of $1.9 million in 2022.
- Across the five-year window, Revenue tumbled 88.62% in 2023 and jumped 8990.91% in 2024, its largest moves.
- Year by year, Revenue stood at $4.2 million in 2020, then advanced by 19.72% to $5.1 million in 2021, then plunged by 86.46% to $685000.0 in 2022, then gained by 27.15% to $871000.0 in 2023, then soared by 9084.85% to $80.0 million in 2024.
- Per Business Quant data, the three most recent Revenue figures were $80.0 million in Q2 2024, $871000.0 in Q4 2023, and $759000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1.30 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Fulcrum Therapeutics | 285.43 Mn | 285.43 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 80.00 Mn |
| Dec 31, 2023 | 871,000.00 |
| Sep 30, 2023 | 759,000.00 |
| Jun 30, 2023 | 880,000.00 |
| Mar 31, 2023 | 295,000.00 |
| Dec 31, 2022 | 685,000.00 |
| Sep 30, 2022 | 1.18 Mn |
| Jun 30, 2022 | 1.88 Mn |
| Mar 31, 2022 | 2.59 Mn |
| Dec 31, 2021 | 5.06 Mn |
| Sep 30, 2021 | 4.94 Mn |
| Jun 30, 2021 | 4.38 Mn |
| Mar 31, 2021 | 4.79 Mn |
| Dec 31, 2020 | 4.23 Mn |
| Sep 30, 2020 | 1.85 Mn |
| Jun 30, 2020 | 2.00 Mn |
| Mar 31, 2020 | 750,000.00 |